FDA Inspection 1057702 — High Point Regional Health System
The FDA completed an inspection of High Point Regional Health System on June 25, 2018 in High Point, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 25, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- High Point, NC (United States)